Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Amyotrophic Lateral Sclerosis (ALS) Treatment will have significant change from previous year. By the most conservative estimates of global Amyotrophic Lateral Sclerosis (ALS) Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 271 million in 2020. Over the next five years the Amyotrophic Lateral Sclerosis (ALS) Treatment market will register a 8.4% CAGR in terms of revenue, the global market size will reach US$ 374.2 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Riluzole
Edaravone (Radicava)
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2016-2026
2.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Type
2.2.1 Riluzole
2.2.2 Riluzole
2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
2.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Type
2.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
2.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
2.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Application
2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Players
3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2019-2021E)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Amyotrophic Lateral Sclerosis (ALS) Treatment by Regions
4.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2016-2021)
4.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2016-2021)
4.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2016-2021)
4.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth (2016-2021)
5 Americas
5.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021)
5.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
5.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2016-2021)
6.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
6.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment by Country (2016-2021)
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment by Region (2016-2021)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions (2021-2026)
10.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast
10.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Countries (2021-2026)
10.2.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Region (2021-2026)
10.3.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Country (2021-2026)
10.4.1 Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Type (2021-2026)
10.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Information
11.1.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Mitsubishi Tanabe Pharma Main Business Overview
11.1.5 Mitsubishi Tanabe Pharma Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Information
11.3.2 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Mylan Pharma Main Business Overview
11.3.5 Mylan Pharma Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Company Information
11.6.2 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Covis Pharma Main Business Overview
11.6.5 Covis Pharma Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of Other
Table 5. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
Table 8. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2019-2021E)
Table 13. Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Products Offered
Table 14. Amyotrophic Lateral Sclerosis (ALS) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Regions 2016-2021
Table 19. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country (2016-2021)
Table 21. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
Table 23. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
Table 25. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region (2016-2021)
Table 27. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
Table 29. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
Table 31. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country (2016-2021)
Table 33. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
Table 35. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 44. Key Application and Potential Industries of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 45. Key Challenges of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 46. Key Trends of Amyotrophic Lateral Sclerosis (ALS) Treatment
Table 47. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 53. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 54. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 55. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Mitsubishi Tanabe Pharma Main Business
Table 57. Mitsubishi Tanabe Pharma Latest Developments
Table 58. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 59. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 60. Sanofi Main Business
Table 61. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Sanofi Latest Developments
Table 63. Mylan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 64. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 65. Mylan Pharma Main Business
Table 66. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Mylan Pharma Latest Developments
Table 68. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 69. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 70. Apotex Main Business
Table 71. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Apotex Latest Developments
Table 73. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 74. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 75. Glemark Generics Main Business
Table 76. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Glemark Generics Latest Developments
Table 78. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 79. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 80. Covis Pharma Main Business
Table 81. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Covis Pharma Latest Developments
Table 83. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 84. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 85. Sun Pharma Main Business
Table 86. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Sun Pharma Latest Developments
Table 88. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis (ALS) Treatment Area Served and Its Competitors
Table 89. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
Table 90. Lunan Pharma Main Business
Table 91. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Lunan Pharma Latest Developments
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2020
Figure 7. Amyotrophic Lateral Sclerosis (ALS) Treatment in Hospital
Figure 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Amyotrophic Lateral Sclerosis (ALS) Treatment in Drugs Store
Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Drugs Store (2016-2021) & ($ Millions)
Figure 11. Amyotrophic Lateral Sclerosis (ALS) Treatment in Other
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2020
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Player in 2020
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2016-2021 ($ Millions)
Figure 17. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2016-2021 ($ Millions)
Figure 20. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country in 2020
Figure 21. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2020
Figure 22. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2020
Figure 23. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Regions in 2020
Figure 27. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2020
Figure 28. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2020
Figure 29. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Country in 2020
Figure 36. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2020
Figure 37. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2020
Figure 38. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application in 2020
Figure 46. Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 52. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 53. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 55. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 59. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 63. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 66. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 67. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2021-2026 ($ Millions)
